JD Health International Inc. (JDHIY)
OTCMKTS
· Delayed Price · Currency is USD
5.10
-0.10 (-1.92%)
At close: May 15, 2025
JD Health International Revenue
In the year 2024, JD Health International had annual revenue of 58.16B CNY with 8.65% growth. JD Health International had revenue of 29.82B in the half year ending December 31, 2024, with 12.47% growth.
Revenue
58.16B CNY
Revenue Growth
+8.65%
P/S Ratio
2.08
Revenue / Employee
16.32M CNY
Employees
3,564
Market Cap
16.55B USD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |
JD Health International News
- 2 months ago - JD Health International Inc. (JDHIF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - JD Health: Becoming Bullish On Tailwinds And Catalysts (Rating Upgrade) - Seeking Alpha
- 1 year ago - ‘The China equity trade is back' and here are the stocks to pick, says SocGen - Market Watch
- 1 year ago - JD Health International Inc. (JDHIF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - JD Health International Inc. (JDHIF) Q4 2022 Earnings Call Transcript - Seeking Alpha
- 2 years ago - JD Health International Inc. (JDHIF) CEO Enlin Jin on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha